BioSpace News Archive

Ciming Boao International Hospital and Fertility Center, a state-of-the-art 5,000sq meter facility has begun trial operations.

CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for atrial fibrillation (AFib), today announced the European CE Mark approval of the HeartLight X3 Endoscopic Ablation System.

Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body’s immune system to fight cancer, today announced that the Hunter Holmes McGuire VA Medical Center (VAMC) located in Richmond, VA has joined its ongoing prostate cancer Cchek™ study. Study enrollment will be led by Dr. Michael G. Chang, Service Chief, within the Radiation Oncology Department.

Greatest ppFEV1 Improvement Shown in High Dose Triplet with Mean Absolute Improvement in ppFEV1 of 8 Percentage Points at 14 Days Compared to Placebo (p<0.05) in Subjects with Two F508del Mutations (F/F) Not Predisposed to Rapid Pulmonary Decline

Phio Pharmaceuticals Corp. announced that the Company will present a poster at the American Association for Cancer Research Annual Meeting 2019, which will be held from March 29–April 1, 2019 at the Georgia World Congress Center in Atlanta, Georgia.

Four Posters Will Present BIJUVA Phase 3 REPLENISH Data About Improvements in Hot Flushes, Night Sweats, Sweating, Quality of Sleep, and Incidence of Vaginal Bleeding in Postmenopausal Women

Data presented at International Society of Ocular Oncology (ISOO) 2019 Conference

Urges Shareholders to Vote “FOR” the Proposed Transaction on the WHITE Proxy Card

New working capital intended to advance Ehave’s development of digital assessments and therapeutic games for children with ADD/ADHD, ASD, and other mental health disorders.

Curis, Inc. announced that the Company will release its fourth quarter and full-year 2018 financial results on Tuesday, March 26, 2019, after the close of the US markets.